Microlax (Sorbitol, Liquid (Crystallising), Sodium Citrate, Sodium Lauryl Sulfoacetate 70%)

Sorbitol creates an osmotic gradient that draws water into the colon, softening stool and increasing intestinal volume. This, together with the surfactant action of sodium lauryl sulfoacetate, stimulates colonic motility and promotes prompt evacuation.

The appropriate dose of Microlax is determined by the prescribing healthcare professional based on the patient’s age, condition, and clinical needs. The product is supplied as a pre‑measured enema solution for single‑use administration.

Pregnant or breastfeeding individuals should consult their healthcare provider before using Microlax. While the product is generally considered low risk, professional guidance is essential to weigh any potential benefits against possible risks.

To order Microlax, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Microlax provides a rapid, localized effect via rectal administration, unlike oral osmotic laxatives that act systemically. Its enema form offers quicker relief and is often preferred for bowel preparation before procedures, whereas oral agents may be used for chronic constipation management.

Microlax should be stored at room temperature, away from direct sunlight and moisture. Keep the container tightly closed in its original packaging until use to maintain product stability and efficacy.

Microlax is administered rectally as a single‑use enema. The patient lies on their side, inserts the nozzle gently into the rectum, and releases the solution. The product typically works within minutes, prompting a bowel movement.

Serious risks include severe abdominal pain, rectal bleeding, and allergic reactions such as rash or difficulty breathing. If any of these occur, medical attention should be sought immediately.

Microlax should be avoided by individuals with known intestinal obstruction, active inflammatory bowel disease flare, severe electrolyte imbalance, or those who are allergic to any of its ingredients. Children under three years of age should not use it without medical supervision.